These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Hirama M; Takahashi F; Takahashi K; Akutagawa S; Shimizu K; Soma S; Shimanuki Y; Nishio K; Fukuchi Y Cancer Lett; 2003 Jul; 198(1):107-17. PubMed ID: 12893437 [TBL] [Abstract][Full Text] [Related]
3. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Zeng G; Gao L; Birklé S; Yu RK Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of neuroblastoma-induced angiogenesis by fenretinide. Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754 [TBL] [Abstract][Full Text] [Related]
6. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158 [TBL] [Abstract][Full Text] [Related]
7. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and osteopontin in tumor biology. Shijubo N; Uede T; Kon S; Nagata M; Abe S Crit Rev Oncog; 2000; 11(2):135-46. PubMed ID: 11005509 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818 [TBL] [Abstract][Full Text] [Related]
11. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282 [TBL] [Abstract][Full Text] [Related]
12. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. Wu XL; Lin KJ; Bai AP; Wang WX; Meng XK; Su XL; Hou MX; Dong PD; Zhang JJ; Wang ZY; Shi L World J Gastroenterol; 2014 Aug; 20(30):10440-8. PubMed ID: 25132760 [TBL] [Abstract][Full Text] [Related]
13. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor. Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256 [TBL] [Abstract][Full Text] [Related]
16. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392 [TBL] [Abstract][Full Text] [Related]
18. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor. Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. Mu J; Abe Y; Tsutsui T; Yamamoto N; Tai XG; Niwa O; Tsujimura T; Sato B; Terano H; Fujiwara H; Hamaoka T Jpn J Cancer Res; 1996 Sep; 87(9):963-71. PubMed ID: 8878460 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Marti HJ; Bernaudin M; Bellail A; Schoch H; Euler M; Petit E; Risau W Am J Pathol; 2000 Mar; 156(3):965-76. PubMed ID: 10702412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]